Nosocomial diskitis due to Propionibacterium acnes.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 9617690)

Published in J Hosp Infect on May 01, 1998

Authors

J Esteban, R Calvo, M Pardeiro, F Soriano

Articles citing this

Treatment of Surgical Site Infection in Posterior Lumbar Interbody Fusion. Asian Spine J (2015) 0.80

Articles by these authors

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91

Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis (1996) 2.33

Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms. J Clin Microbiol (1985) 2.01

Cutaneous tuberculosis: a clinical, histopathologic, and bacteriologic study. J Am Acad Dermatol (1995) 1.90

Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89

The electronic structure of Fe2+ in reaction centers from Rhodopseudomonas sphaeroides. III. EPR measurements of the reduced acceptor complex. Biophys J (1984) 1.85

Location of the serine residue involved in the linkage between the terminal protein and the DNA of phage phi 29. Nucleic Acids Res (1985) 1.68

Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart (2003) 1.55

In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum). J Clin Microbiol (1986) 1.54

Antimicrobial susceptibility of Corynebacterium group D2. Antimicrob Agents Chemother (1985) 1.54

Primary structure and inhibition of protein synthesis in eukaryotic cell-free system of a novel thionin, gamma-hordothionin, from barley endosperm. Eur J Biochem (1990) 1.49

Monocytoid B-cell lymphoma. Am J Surg Pathol (1989) 1.47

A case of Hirayama disease treated with laminectomy and duraplasty without spinal fusion. Neurocirugia (Astur) (2009) 1.47

[Soft-tissue infection caused by Aeromonas hydrophila]. Enferm Infecc Microbiol Clin (1995) 1.46

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45

Evaluation of API Coryne system for identifying coryneform bacteria. J Clin Pathol (1994) 1.44

Improved direct epifluorescent filter technique for rapid bioburden control in intravenous solutions. J Parenter Sci Technol (1992) 1.38

Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrob Agents Chemother (1987) 1.33

Protein-cofactor interactions in bacterial reaction centers from Rhodobacter sphaeroides R-26: II. Geometry of the hydrogen bonds to the primary quinone formula by 1H and 2H ENDOR spectroscopy. Biophys J (2006) 1.29

Serum protein binding of propofol in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand (1996) 1.24

In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials. Antimicrob Agents Chemother (1998) 1.24

Classification of coryneform bacteria associated with human urinary tract infection (group D2) as Corynebacterium urealyticum sp. nov. Int J Syst Bacteriol (1992) 1.20

Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab (1993) 1.18

Isolation of Propionibacterium acnes from central nervous system infections. Anaerobe (1995) 1.18

Bacteriuria with a multiply resistant species of Corynebacterium (Corynebacterium group D2): an unnoticed cause of urinary tract infection. J Infect Dis (1987) 1.16

Serum protein binding of propofol in critically ill patients. Acta Anaesthesiol Scand (1997) 1.11

Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol (1996) 1.11

The significance of lipoproteins in serum binding variations of propofol. Anesth Analg (1998) 1.11

Measurement of biofilm formation by clinical isolates of Escherichia coli is method-dependent. J Appl Microbiol (2008) 1.07

Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta (1993) 1.07

Bordetella hinzii, a "new" opportunistic pathogen to think about. J Infect (2000) 1.05

Simian virus 40 in a human cancer. Nature (1974) 1.05

Thyroid hormones in tissues from fetal and adult rats. Endocrinology (1994) 1.04

Complete amino acid sequence of the Aspergillus cytotoxin mitogillin. Biochemistry (1985) 1.03

NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol (2002) 1.02

Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment. Biochemistry (1991) 1.02

Primary structure of the activation segment of procarboxypeptidase A from porcine pancreas. Biochem Biophys Res Commun (1986) 1.00

Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement. Ann Intern Med (1988) 1.00

In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother (2000) 1.00

DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene (1999) 1.00

Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. Eur J Clin Microbiol Infect Dis (1988) 1.00

Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis (1989) 1.00

Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res (2006) 0.99

Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Inflamm Res (1996) 0.98

Infection caused by the nonfermentative gram-negative bacillus CDC group IV c-2: case report and literature review. Eur J Clin Microbiol Infect Dis (1993) 0.97

In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother (2008) 0.96

Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem. Antimicrob Agents Chemother (1996) 0.96

Bactericidal activity of chloramphenicol, clindamycin, metronidazole and cefoxitin against Bacteroides fragilis. J Antimicrob Chemother (1980) 0.96

Bacteroides fragilis resistant to clindamycin. J Antimicrob Chemother (1981) 0.96

Peritonitis with CDC group IVc-2 bacteria in a patient on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis (1991) 0.95

Protein-cofactor interactions in bacterial reaction centers from Rhodobacter sphaeroides R-26: I. Identification of the ENDOR lines associated with the hydrogen bonds to the primary quinone QA*-. Biophys J (2006) 0.95

Six cases in which mesenteric lymphadenitis due to non-typhi Salmonella caused an appendicitis-like syndrome. Clin Infect Dis (1995) 0.95

Search for perinatal viral infection. A prospective, clinical, virologic, and serologic study. Am J Dis Child (1968) 0.95

High rates of erythromycin-resistant Streptococcus pneumoniae among penicillin-resistant strains. J Antimicrob Chemother (1993) 0.94

Injury to the infrapatellar branch of the saphenous nerve in ACL reconstruction with the hamstrings technique: clinical and electrophysiological study. Knee (2008) 0.94

Outer ring iodothyronine deiodinases and thyroid hormone economy: responses to iodine deficiency in the rat fetus and neonate. Endocrinology (1991) 0.94

Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. Ann Oncol (1998) 0.93

Isolation of Corynebacterium ureicelerivorans from normally sterile sites in humans. Eur J Clin Microbiol Infect Dis (2008) 0.93

The susceptibility of Yersinia to eleven antimicrobials. J Antimicrob Chemother (1982) 0.93

[Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature]. Enferm Infecc Microbiol Clin (1997) 0.93

Long term evaluation of high tibial valgus osteotomy. Int Orthop (1990) 0.93

Thyroid hormones and 5'-deiodinase in the rat fetus late in gestation: effects of maternal hypothyroidism. Endocrinology (1991) 0.93

Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts. J Antimicrob Chemother (1997) 0.93

L-thyroxine and 3,5,3'-triiodothyronine concentrations in the chicken egg and in the embryo before and after the onset of thyroid function. Endocrinology (1992) 0.93

Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters. Clin Microbiol Infect (2009) 0.93

Binding of propofol to blood components. Br J Clin Pharmacol (2000) 0.92

Surgical wound infections due to Propionibacterium acnes: a study of 10 cases. J Hosp Infect (1995) 0.92

Failure of Gram stain to detect Propionibacterium acnes in specimens from clinically significant infections. J Clin Microbiol (1996) 0.92

Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J Med Chem (1991) 0.92

Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994. Eur J Clin Microbiol Infect Dis (1996) 0.92

Purification and properties of five different forms of human procarboxypeptidases. Eur J Biochem (1989) 0.92

Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis (1999) 0.92

Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther (1980) 0.92

SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet (2012) 0.91

In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium. Int J Antimicrob Agents (2009) 0.91

Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project. Int J Antimicrob Agents (2004) 0.91

Protein reverse staining: high-efficiency microanalysis of unmodified proteins detected on electrophoresis gels. Anal Biochem (1995) 0.91

Simple immunodiffusion test for detecting antibodies against Legionella pneumophila serotype 1. J Clin Microbiol (1982) 0.91

Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients. J Clin Pharm Ther (2005) 0.90

Problems in minimum inhibitory concentration determinations in coryneform organisms. Comparison of an agar dilution and the Etest. Diagn Microbiol Infect Dis (1994) 0.90

Classifying extraintestinal non-typhoid Salmonella infections. QJM (1996) 0.90

Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection (1996) 0.90

Long interval between HCV infection and development of hepatocellular carcinoma. Liver (1995) 0.90

Pseudomonas species Ve-2 septicemia. Eur J Clin Microbiol (1986) 0.90

Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis (1994) 0.90

Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord (1996) 0.90

Reduced survival in patients with stage-I non-small-cell lung cancer associated with DNA-replication errors. Int J Cancer (1997) 0.90

Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats. J Pharmacol Exp Ther (1999) 0.90

[Osteoarticular infections by Salmonella non-typhi]. Enferm Infecc Microbiol Clin (1996) 0.89

Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord (1995) 0.89

Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet (2000) 0.89

Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect (2009) 0.89